Tiny Biotech Just Beat AbbVie's Drug: Risk for Investors?
A tiny biotech just beat AbbVie's blockbuster in early-stage results, prompting fresh questions about the durability ...
The debate between points and cash back is ongoing. Understand the benefits of each to determine which suits you best.
28,655 articlesA tiny biotech just beat AbbVie's blockbuster in early-stage results, prompting fresh questions about the durability ...
The Nasdaq-100 has delivered eye-catching runs, but 2026 brought a pause. This guide breaks down what to watch, how t...
A new stake lift from Bright Valley Capital highlights a high-stakes bet on Vipshop’s rebound. We break down what it ...
In June, Lemonade stock surged about 12% as investors weighed progress on its reinsurance strategy and AI-driven grow...
A landmark listed on the NYSE signals bigger access to capital and greater scrutiny for cannabis companies. Learn how...
A viral political moment can ripple into your personal finances. This article explains the SAVE Act, why gridlock mat...
A sharp 34% June rally in Sandisk highlights a changing memory market. Explore the forces behind the move, what it me...
AMC stunned traders with a profitability surprise that sent its shares higher. This piece breaks down the catalysts, ...
Aurora Mobile's Q1 2026 earnings reveal a mix of solid growth and evolving margins. This piece breaks down what the t...
Core Scientific reports higher first-quarter revenue and gross profit, yet a net loss due to impairment charges derai...
A major investor stepped into Crocs with a sizable new stake, valuing the position at about $53.7 million even as CRO...
SpaceX is partnering with Anthropic to unlock massive AI compute at a Tennessee data center. This could reshape Anthr...